146
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Prognostic Role of Geriatric Nutritional Risk Index in Patients with Pancreatic Cancer: A Meta-Analysis

&
Pages 1531-1540 | Received 06 Feb 2023, Accepted 26 Apr 2023, Published online: 10 May 2023

Reference

  • Rawla P, Sunkara T, Gaduputi V. Epidemiology of pancreatic cancer: global trends, etiology and risk factors. World J Oncol. 2019;10(1):10–27. doi: 10.14740/wjon1166.
  • Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. doi: 10.3322/caac.21660.
  • Mizrahi JD, Surana R, Valle JW, Shroff RT. Pancreatic cancer. Lancet. 2020;395(10242):2008–20. doi: 10.1016/s0140-6736(20)30974-0.
  • Park W, Chawla A, O’Reilly EM. Pancreatic cancer: a review. Jama. 2021;326(9):851–62. doi: 10.1001/jama.2021.13027.
  • Kwon W-A, Kim S, Kim SH, Joung JY, Seo HK, Lee KH, Chung J. Pretreatment prognostic nutritional index is an independent predictor of survival in patients with metastatic renal cell carcinoma treated with targeted therapy. Clin Genitourin Cancer. 2017;15(1):100–11. doi: 10.1016/j.clgc.2016.07.025.
  • Saito H, Kono Y, Murakami Y, Shishido Y, Kuroda H, Matsunaga T, Fukumoto Y, Osaki T, Ashida K, Fujiwara Y, et al. Prognostic significance of the preoperative ratio of c-reactive protein to albumin and neutrophil-lymphocyte ratio in gastric cancer patients. World J Surg. 2018;42(6):1819–25. doi: 10.1007/s00268-017-4400-1.
  • Fang P, Yang Q, Zhou J, Yang Y, Luan S, Xiao X, Li X, Gu Y, Shang Q, Zhang H, et al. The impact of geriatric nutritional risk index on esophageal squamous cell carcinoma patients with neoadjuvant therapy followed by esophagectomy. Front Nutr. 2022;9:983038. doi: 10.3389/fnut.2022.983038.
  • Kinoshita A, Hagiwara N, Osawa A, Akasu T, Matsumoto Y, Ueda K, Saeki C, Oikawa T, Koike K, Saruta M, et al. The geriatric nutritional risk index predicts tolerability of lenvatinib in patients with hepatocellular carcinoma. In Vivo. 2022;36(2):865–73. doi: 10.21873/invivo.12775.
  • Dai H, Xu J. Preoperative geriatric nutritional risk index is an independent prognostic factor for postoperative survival after gallbladder cancer radical surgery. BMC Surg. 2022;22(1):133. doi: 10.1186/s12893-022-01575-2.
  • Chen Z, Zhong M, Xu Z, Ye Q, Xie W, Gao S, Chen L, Qiu L, Jiang J, Wu H, et al. Development and validation of a nomogram based on geriatric nutritional risk index to predict surgical site infection among gynecologic oncology patients. Front Nutr. 2022;9:864761. doi: 10.3389/fnut.2022.864761.
  • Atas U, Sozel H, Iltar U, Yucel OK, Salim O, Undar L. The prognostic impact of pretreatment geriatric nutritional risk index in patients with diffuse large B-cell lymphoma. Nutr Cancer. 2023;75(2):591–8. doi: 10.1080/01635581.2022.2142248.
  • Ito Y, Abe A, Hayashi H, Momokita M, Furuta H. Prognostic impact of preoperative geriatric nutritional risk index in oral squamous cell carcinoma. Oral Dis. 2022; doi: 10.1111/odi.14255. Online ahead of print.
  • Balzano G, Dugnani E, Crippa S, Scavini M, Pasquale V, Aleotti F, Liberati D, Gandolfi A, Belfiori G, Reni M, et al. A preoperative score to predict early death after pancreatic cancer resection. Dig Liver Dis. 2017;49(9):1050–6. doi: 10.1016/j.dld.2017.06.012.
  • Hu S-P, Chen L, Lin C-Y, Lin W-H, Fang F-Q, Tu M-Y. The prognostic value of preoperative geriatric nutritional risk index in patients with pancreatic ductal adenocarcinoma. Cancer Manag Res. 2020;12:385–95. doi: 10.2147/cmar.S229341.
  • Itoh S, Tsujita E, Fukuzawa K, Sugimachi K, Iguchi T, Ninomiya M, Maeda T, Kajiyama K, Adachi E, Uchiyama H, et al. Prognostic significance of preoperative PNI and CA19-9 for pancreatic ductal adenocarcinoma: a multi-institutional retrospective study. Pancreatology. 2021;21(7):1356–63. doi: 10.1016/j.pan.2021.08.003.
  • Sakamoto T, Yagyu T, Uchinaka E, Miyatani K, Hanaki T, Kihara K, Matsunaga T, Yamamoto M, Tokuyasu N, Honjo S, et al. The prognostic significance of combined geriatric nutritional risk index and psoas muscle volume in older patients with pancreatic cancer. BMC Cancer. 2021;21(1):342. doi: 10.1186/s12885-021-08094-y.
  • Funamizu N, Sakamoto A, Utsunomiya T, Uraoka M, Nagaoka T, Iwata M, Ito C, Tamura K, Sakamoto K, Ogawa K, et al. Geriatric nutritional risk index as a potential prognostic marker for patients with resectable pancreatic cancer: a single-center, retrospective cohort study. Sci Rep. 2022;12(1):13644. doi: 10.1038/s41598-022-18077-z.
  • Grinstead C, George T, Han B, Yoon SL. Associations of overall survival with geriatric nutritional risk index in patients with advanced pancreatic cancer. Nutrients. 2022;14(18):3800. doi: 10.3390/nu14183800.
  • Moher D, Liberati A, Tetzlaff J, Altman DG, Grp P, The PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. doi: 10.1371/journal.pmed.1000097.
  • Bouillanne O, Morineau G, Dupont C, Coulombel I, Vincent J-P, Nicolis I, Benazeth S, Cynober L, Aussel C. Geriatric Nutritional risk index: a new index for evaluating at-risk elderly medical patients. Am J Clin Nutr. 2005;82(4):777–83. doi: 10.1093/ajcn/82.4.777.
  • Wells GA, Shea B, O’Connell D, Peterson J, Welch V, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available at: http://wwwohrica/programs/clinical_epidemiology/oxfordasp.
  • Sachlova M, Majek O, Tucek S. Prognostic value of scores based on malnutrition or systemic inflammatory response in patients with metastatic or recurrent gastric cancer. Nutr Cancer. 2014;66(8):1362–70. doi: 10.1080/01635581.2014.956261.
  • Gupta D, Lis CG. Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr J. 2010;9:69. doi: 10.1186/1475-2891-9-69.
  • Li H, Chen C, Li Z-M, Yang Y, Xing C-Q, Li Y, Jin Y-H. Specific interaction with human serum albumin reduces ginsenoside cytotoxicity in human umbilical vein endothelial cells. Front Pharmacol. 2020;11:498. doi: 10.3389/fphar.2020.00498.
  • Chojkier M. Inhibition of albumin synthesis in chronic diseases: molecular mechanisms. J Clin Gastroenterol. 2005;39(4 Suppl 2):S143–S6. doi: 10.1097/01.mcg.0000155514.17715.39.
  • Yuan C, Bao Y, Wu C, Kraft P, Ogino S, Ng K, Qian ZR, Rubinson DA, Stampfer MJ, Giovannucci EL, et al. Prediagnostic body mass index and pancreatic cancer survival. J Clin Oncol. 2013;31(33):4229–34. doi: 10.1200/jco.2013.51.7532.
  • Pierobon ES, Moletta L, Zampieri S, Sartori R, Brazzale AR, Zanchettin G, Serafini S, Capovilla G, Valmasoni M, Merigliano S, et al. The Prognostic Value of Low Muscle Mass in Pancreatic Cancer Patients: a Systematic Review and Meta-Analysis. JCM. 2021;10(14):3033. doi: 10.3390/jcm10143033.
  • Bundred J, Kamarajah SK, Roberts KJ. Body composition assessment and sarcopenia in patients with pancreatic cancer: a systematic review and meta-analysis. HPB (Oxford). 2019;21(12):1603–12. doi: 10.1016/j.hpb.2019.05.018.
  • Blum D, Stene GB, Solheim TS, Fayers P, Hjermstad MJ, Baracos VE, Fearon K, Strasser F, Kaasa S, Validation of the consensus-definition for cancer cachexia and evaluation of a classification model–a study based on data from an international multicentre project (EPCRC-CSA). Ann Oncol. 2014;25(8):1635–42. doi: 10.1093/annonc/mdu086.
  • Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12(5):489–95. doi: 10.1016/s1470-2045(10)70218-7.
  • Lidoriki I, Schizas D, Frountzas M, Machairas N, Prodromidou A, Kapelouzou A, Karavokyros I, Pikoulis E, Kales SN, Liakakos T, et al. GNRI as a Prognostic Factor for Outcomes in Cancer Patients: a Systematic Review of the Literature. Nutr Cancer. 2021;73(3):391–403. doi: 10.1080/01635581.2020.1756350.
  • Fan H, Ma W, Fu Y, Yi T, Tian J. Association of geriatric nutritional risk index with survival outcomes in patients with esophageal squamous cell carcinoma: a meta-analysis. Nutr Cancer,. 2022;74(8):2796–802. doi: 10.1080/01635581.2022.2028865.
  • Shen F, Ma Y, Guo W, Li F. Prognostic value of geriatric nutritional risk index for patients with non-small cell lung cancer: a systematic review and meta-analysis. Lung. 2022;200(5):661–9. doi: 10.1007/s00408-022-00567-6.
  • Lv GY, An L, Sun DW. Geriatric nutritional risk index predicts adverse outcomes in human malignancy: a meta-analysis. Dis Markers. 2019;2019:4796598. doi: 10.1155/2019/4796598.
  • Xu J, Sun Y, Gong D, Fan Y. Predictive value of geriatric nutritional risk index in patients with colorectal cancer: a meta-analysis. Nutr Cancer. 2023;75(1):24–32. doi: 10.1080/01635581.2022.2115521.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.